Evidence map›Paper›PMID 29631083›Full record

ArticleWorld neurosurgery2018

Glioblastoma Survival Outcomes at a Tertiary Hospital in Appalachia: Factors Impacting the Survival of Patients Following Implementation of the Stupp Protocol.

Ogaga Urhie, Ryan Turner, Brandon Lucke-Wold, Walid Radwan, Janice Ahn, Kymberly Gyure, Sanjay Bhatia

Abstract read
In one paragraph

Article in World neurosurgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Therapeutic efficacy ofFrontiers in oncology · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ogaga UrhieWest Virginia University School of Medicine, Morgantown, West Virginia, USA; Department of Neurosurgery, West Virginia University Hospitals, Morgantown, West Virginia, USA.
Ryan TurnerDepartment of Neurosurgery, West Virginia University Hospitals, Morgantown, West Virginia, USA.
Brandon Lucke-WoldWest Virginia University School of Medicine, Morgantown, West Virginia, USA; Department of Neurosurgery, West Virginia University Hospitals, Morgantown, West Virginia, USA.
Walid RadwanDepartment of Neurosurgery, West Virginia University Hospitals, Morgantown, West Virginia, USA.
Janice AhnDepartment of Pathology and Neurology, West Virginia University Health Sciences Campus, Morgantown, West Virginia, USA.
Kymberly GyureDepartment of Pathology and Neurology, West Virginia University Health Sciences Campus, Morgantown, West Virginia, USA.
Sanjay BhatiaDepartment of Neurosurgery, West Virginia University Hospitals, Morgantown, West Virginia, USA. Electronic address: sbhatia@hsc.wvu.edu.

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

backgroundGlioblastoma is a fatal brain cancer with low median and yearly survival rates. Standard of care for treating glioblastoma is gross total resection (GTR) coupled with the Stupp protocol, but various factors influence the interventions undertaken and survival achieved. As health disparities exist in rural areas, survival in these areas needs to be assessed to understand which factors detract from the successes of these standard medical interventions.

methodsWe retrospectively determined impact of age at diagnosis, number of lesions, the molecular marker O

resultsAge <60 years at diagnosis, having the MGMT gene methylated, having a unifocal tumor, receiving GTR, adhering to the Stupp protocol, and undergoing a treatment course of GTR followed by the Stupp protocol significantly increased survival. Comparison with the 1996 study showed that although overall median survival has not increased, all interventions involving GTR have resulted in a significantly higher survival.

conclusionsWe can serve our patient population by offering GTR to all adult patients with glioblastoma when no contraindications exist and ensuring that patients follow the Stupp protocol. After discharge, the Stupp protocol may not be followed or completed for a variety of reasons. In the future, we aim to assess these reasons and analyze other significant interventional and socioeconomic factors that influence survival.

Indexed as

AdultAgedAged, 80 and overAntineoplastic ProtocolsAppalachian RegionBiomarkers, TumorBrain NeoplasmsCohort StudiesDNA Modification MethylasesDNA Repair EnzymesFemaleGlioblastomaHealthcare DisparitiesHealth LiteracyHumansMaleBiomarkers, TumorDNA Modification MethylasesDNA Repair EnzymesMGMT protein, humanTumor Suppressor ProteinsAppalachiaGlioblastomaGross total resection (GTR)Median survivalRural areasStupp protocolWest Virginia

Identifiers

PMID29631083
PMCPMC6026477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.